Bergamottin a CYP3A inhibitor found in grapefruit juice inhibits prostate cancer cell growth by downregulating androgen receptor signaling and promoting G0/G1 cell cycle block and apoptosis

Prostate cancer is the second leading cause of cancer related death in American men. Several therapies have been developed to treat advanced prostate cancer, but these therapies often have severe side effects. To improve the outcome with fewer side effects we focused on the furanocoumarin bergamottin, a natural product found in grapefruit juice and a potent CYP3A inhibitor. Our recent studies have shown that CYP3A5 inhibition can block androgen receptor (AR) signaling, critical for prostate cancer growth. We observed that bergamottin reduces prostate cancer (PC) cell growth by decreasing both total and nuclear AR (AR activation) reducing downstream AR signaling. Bergamottin’s role in reducing AR activation was confirmed by confocal microscopy studies and reduction in prostate specific antigen (PSA) levels, which is a marker for prostate cancer. Further studies revealed that bergamottin promotes cell cycle block and accumulates G0/G1 cells. The cell cycle block was accompanied with reduction in cyclin D, cyclin B, CDK4, P-cdc2 (Y15) and P-wee1 (S642). We also observed that bergamottin triggers apoptosis in prostate cancer cell lines as evident by TUNEL staining and PARP cleavage. Our data suggests that bergamottin may suppress prostate cancer growth, especially in African American (AA) patients carrying wild type CYP3A5 often presenting aggressive disease.

[1]  R. Capasso,et al.  Anticancer Potential of Furanocoumarins: Mechanistic and Therapeutic Aspects , 2020, International journal of molecular sciences.

[2]  C. Gahn,et al.  The Grapefruit Effect: Interaction between Cytochrome P450 and Coumarin Food Components, Bergamottin, Fraxidin and Osthole. X-ray Crystal Structure and DFT Studies , 2020, Molecules.

[3]  R. Kittles,et al.  Role of CYP3A5 in Modulating Androgen Receptor Signaling and Its Relevance to African American Men with Prostate Cancer , 2020, bioRxiv.

[4]  P. Rajendran,et al.  The Multifarious Link between Cytochrome P450s and Cancer , 2020, Oxidative medicine and cellular longevity.

[5]  A. Jemal,et al.  Cancer statistics for African Americans, 2019 , 2019, CA: a cancer journal for clinicians.

[6]  G. Sethi,et al.  Pharmacological Utilization of Bergamottin, Derived from Grapefruits, in Cancer Prevention and Therapy , 2018, International journal of molecular sciences.

[7]  E. Scott,et al.  Structures of human cytochrome P450 1A1 with bergamottin and erlotinib reveal active-site modifications for binding of diverse ligands , 2018, The Journal of Biological Chemistry.

[8]  S. Awale,et al.  Chemical Constituents of Thai Citrus hystrix and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line. , 2018, Journal of natural products.

[9]  G. Sethi,et al.  Bergamottin Suppresses Metastasis of Lung Cancer Cells through Abrogation of Diverse Oncogenic Signaling Cascades and Epithelial-to-Mesenchymal Transition , 2018, Molecules.

[10]  H. Schatten.  Brief Overview of Prostate Cancer Statistics, Grading, Diagnosis and Treatment Strategies. , 2018, Advances in experimental medicine and biology.

[11]  Yilong Liu,et al.  Characterization and Purification of Bergamottin from Citrus grandis (L.) Osbeck cv. Yongjiazaoxiangyou and Its Antiproliferative Activity and Effect on Glucose Consumption in HepG2 cells , 2017, Molecules.

[12]  Joseph G. Ibrahim,et al.  Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells , 2017, npj Breast Cancer.

[13]  Yu Wang,et al.  Chemistry and health effects of furanocoumarins in grapefruit , 2016, Journal of food and drug analysis.

[14]  Hong-bo Wu,et al.  Bergamottin isolated from Citrus bergamia exerts in vitro and in vivo antitumor activity in lung adenocarcinoma through the induction of apoptosis, cell cycle arrest, mitochondrial membrane potential loss and inhibition of cell migration and invasion. , 2016, Oncology reports.

[15]  K. Ahn,et al.  Simvastatin in combination with bergamottin potentiates TNF-induced apoptosis through modulation of NF-κB signalling pathway in human chronic myelogenous leukaemia , 2016, Pharmaceutical biology.

[16]  P. Ollitrault,et al.  The Distribution of Coumarins and Furanocoumarins in Citrus Species Closely Matches Citrus Phylogeny and Reflects the Organization of Biosynthetic Pathways , 2015, PloS one.

[17]  P. Bramanti,et al.  Effects of bergamot essential oil and its extractive fractions on SH‐SY5Y human neuroblastoma cell growth , 2015, The Journal of pharmacy and pharmacology.

[18]  O. Goodman,et al.  CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR , 2015, The Prostate.

[19]  G. Sethi,et al.  Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cells. , 2014, Cancer letters.

[20]  M. O'Connell,et al.  Cell cycle regulation by checkpoints. , 2014, Methods in molecular biology.

[21]  T. Jarrett,et al.  Androgen Receptor-Target Genes in African American Prostate Cancer Disparities , 2013, Prostate cancer.

[22]  J. J. Espinosa-Aguirre,et al.  Bergamottin is a competitive inhibitor of CYP1A1 and is antimutagenic in the Ames test. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[23]  Russ B Altman,et al.  PharmGKB summary: very important pharmacogene information for CYP3A5. , 2012, Pharmacogenetics and genomics.

[24]  G. V. Chaitanya,et al.  PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration , 2010, Cell Communication and Signaling.

[25]  Y. Hwang,et al.  Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression. , 2010, Molecular nutrition & food research.

[26]  A. Murakami,et al.  Suppressive Effects of Selected Food Phytochemicals on CD74 Expression in NCI-N87 Gastric Carcinoma Cells , 2008, Journal of clinical biochemistry and nutrition.

[27]  J. Vuoristo,et al.  Characterization of androgen-regulated expression of CYP3A5 in human prostate. , 2006, Carcinogenesis.

[28]  Kathleen R. Noon,et al.  Metabolism of Bergamottin by Cytochromes P450 2B6 and 3A5 , 2006, Journal of Pharmacology and Experimental Therapeutics.

[29]  B. Patil,et al.  Furocoumarins from grapefruit juice and their effect on human CYP 3A4 and CYP 1B1 isoenzymes. , 2006, Bioorganic & medicinal chemistry.

[30]  P. Hollenberg,et al.  The Grapefruit Juice Effect Is Not Limited to Cytochrome P450 (P450) 3A4: Evidence for Bergamottin-Dependent Inactivation, Heme Destruction, and Covalent Binding to Protein in P450s 2B6 and 3A5 , 2005, Journal of Pharmacology and Experimental Therapeutics.

[31]  Jiri Bartek,et al.  Cell-cycle checkpoints and cancer , 2004, Nature.

[32]  M. Herin,et al.  Inhibition of in‐vitro simvastatin metabolism in rat liver microsomes by bergamottin, a component of grapefruit juice , 2004, The Journal of pharmacy and pharmacology.

[33]  E. Cook,et al.  PharmGKB Update: II. CYP3A5, Cytochrome P450, Family 3, Subfamily A, Polypeptide 5 , 2004, Pharmacological Reviews.

[34]  G. Coetzee,et al.  Androgen Receptor Signaling , 2004, Cancer Research.

[35]  K. Cutroneo,et al.  Constitutive and inducible expression of cytochromes P4501A (CYP1A1 and CYP1A2) in normal prostate and prostate cancer cells , 2004, Journal of cellular biochemistry.

[36]  Desok Kim,et al.  Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. , 2003, The Journal of urology.

[37]  Tetsuo Satoh,et al.  Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. , 2003, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[38]  H. Kleiner,et al.  Naturally occurring coumarins inhibit human cytochromes P450 and block benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene DNA adduct formation in MCF-7 cells. , 2003, Chemical research in toxicology.

[39]  E. Schuetz,et al.  Genetic contribution to variable human CYP3A-mediated metabolism. , 2002, Advanced drug delivery reviews.

[40]  Ann Daly,et al.  Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression , 2001, Nature Genetics.

[41]  M. Yano,et al.  Isolation of furocoumarins from bergamot fruits as HL-60 differentiation-inducing compounds. , 1999, Journal of agricultural and food chemistry.

[42]  K. He,et al.  Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. , 1998, Chemical research in toxicology.

[43]  D. Johnston,et al.  Establishment of two human prostate cancer cell lines derived from a single bone metastasis. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  W. Baer-Dubowska,et al.  Inhibitory effects of naturally occurring coumarins on the metabolic activation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured mouse keratinocytes. , 1997, Carcinogenesis.

[45]  G. Jenster,et al.  The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[46]  C. Boring,et al.  Cancer statistics for african americans , 1992, CA: a cancer journal for clinicians.

[47]  S. Brown.  BIOSYNTHESIS OF THE COUMARINS. VI. FURTHER STUDIES ON HERNIARIN FORMATION IN LAVENDER. , 1965, Canadian Journal of Biochemistry.

[48]  G. Towers,et al.  Biosynthesis of the coumarins. Tracer studies on coumarin formation in Hierochloe odorata and Melilotus officinalis. , 1960, Canadian journal of biochemistry and physiology.